CAV1 and atrial fibrillation: In the present study, the CSD peptides abolished the TGF-β1-induced activation of Smad 2/3 signal pathway and the expression of collagens I/III in HAFs, demonstrating that Cav-1 may be able to inhibit the atrial fibrosis in AF.